On April 26th, 2024, The Financial Times referenced two projects led by AFAR affiliated experts in a feature on aging research, “Science is closing in on the frailties of old age.”
The article spotlights The Dog Aging Project, founded by AFAR grantees Matt Kaeberlein, PhD, and Daniel Promislow, DPhil, which is helping to advance knowledge of human aging by studying canine longevity and healthspan.
The article also references the AFAR-managed Targeting Aging with Metformin (TAME) Trial, which aims to provide proof of concept that the biology of aging can be targeted through therapeutics.
Dr. Kaeberlein is a 2006 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient, and a 2007 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award recipient. He is also the 2011 recipient of AFAR’s Vincent Cristofalo Rising Star Award in Aging Research.
Dr. Promislow is a 1998 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient and a 2010 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award recipient.
Read the piece, “Science is closing in on the frailties of old age” here.
